Chardan Capital restated their buy rating on shares of CervoMed (NASDAQ:CRVO – Free Report) in a report published on Thursday,Benzinga reports. The brokerage currently has a $55.00 price objective on the stock. Other equities research analysts also recently issued research reports about the company. Morgan Stanley assumed coverage on CervoMed in a report on Friday, […]

Needham & Company LLC reissued their buy rating on shares of Digimarc (NASDAQ:DMRC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $40.00 price objective on the information technology services provider’s stock. Separately, StockNews.com raised Digimarc to a “sell” rating in a research note on […]